A Multicentre UK Study of Outcomes for Locally Advanced Sinonasal Squamous Cell Carcinoma Treated with Adjuvant or Definitive Intensity-modulated Radiotherapy

Autor: Slevin, F. ^{∗, 1}, Pan, S. ^{†, 1}, Mistry, H. ^{‡, ††}, Denholm, M. ^§, Shor, D. ^§, Oong, Z. ^¶, Price, J. ^†, Jadon, R. ^§, Fleming, J.C. ^||, Barnett, G. ^{§, 2}, Dixon, L. ^{∗∗, 2}, Prestwich, R. ^{∗, 2}, Thomson, D. ^{†, ‡, ††, ∗, 2}

Publikováno v: In Clinical Oncology October 2021 33(10):e450-e461

The care of older patients with cancer across the United Kingdom in 2024: A narrative review by the International Society of Geriatric Oncology UK Country Group.

Autor: Gomes F; The Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: fabio.gomes2@nhs.net., Farrington N; The Christie NHS Foundation Trust, Manchester, United Kingdom., Pearce J; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Swinson D; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Welford J; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Greystoke A; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Baxter M; Ninewells Hospital, NHS Tayside, Dundee, Scotland, United Kingdom., Brown-Kerr AG; Ninewells Hospital, NHS Tayside, Dundee, Scotland, United Kingdom., Wyld L; University of Sheffield, Sheffield, United Kingdom., Morgan J; University of Sheffield, Sheffield, United Kingdom., Battisti NML; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Barrell A; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Cobben D; The Clatterbridge Cancer Centre, Liverpool, United Kingdom; Institute of Population Health, University of Liverpool, Liverpool, United Kingdom., Cree A; The Clatterbridge Cancer Centre, Liverpool, United Kingdom., Johnston M; Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom., Colquhoun K; Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom., Phillips I; St John's Hospital, NHS Lothian, Edinburgh, Scotland, United Kingdom; Western General Hospital, NHS Lothian, Edinburgh, Scotland, United Kingdom., Smith J; Western General Hospital, NHS Lothian, Edinburgh, Scotland, United Kingdom., Stapley S; Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom., Lyons L; Antrim Hospital, Northern Health and Social Care Trust, Antrim, Ireland., Balachandran K; Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom., Brown H; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Bryce R; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom., Dacie R; Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom., Parks R; Nottingham Breast Cancer Research Centre and School of Medicine University of Nottingham, Royal Derby Hospital Centre, United Kingdom., Denholm M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Harari D; Guys and St Thomas' NHS Foundation Trust, London, United Kingdom., Rigden T; East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom., Sommer D; University College London Hospitals NHS Trust, London, United Kingdom., Williams K; Velindre Cancer Centre, Velindre NHS Trust, Cardiff, Wales, United Kingdom., Worby K; West Suffolk NHS Foundation Trust, Bury St Edmunds, United Kingdom., Cheung KL; Nottingham Breast Cancer Research Centre and School of Medicine University of Nottingham, Royal Derby Hospital Centre, United Kingdom.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2025 Jan; Vol. 16 (1), pp. 102133. Date of Electronic Publication: 2024 Oct 24.

Inhibition of lung tumorigenesis by transient reprogramming in cancer cells.

Autor: Pedrosa P; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Zhang Z; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Nuñez-Quintela V; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Macias D; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Ge J; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Denholm M; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Dyas A; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK., Estevez-Souto V; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Lado-Fernandez P; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Department of Physiology and Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), Universidad de Santiago de Compostela, Santiago de Compostela, Spain., Gonzalez P; Histopathology Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Gomez M; Histopathology Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martin JE; CMDL, Department of Oncology, SMCL, Department of Medical Genetics, University of Cambridge, Cambridge, UK., Da Silva-Alvarez S; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain., Collado M; Cell Senescence, Cancer and Aging Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. manuel.collado.rodriguez@sergas.es.; Department of Immunology and Oncology (DIO), Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain. manuel.collado.rodriguez@sergas.es., Muñoz-Espín D; Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK. dm742@cam.ac.uk.; CRUK Cambridge Centre Thoracic Cancer Programme, University of Cambridge, Cambridge, UK. dm742@cam.ac.uk.

Publikováno v: Cell death & disease [Cell Death Dis] 2024 Nov 25; Vol. 15 (11), pp. 857. Date of Electronic Publication: 2024 Nov 25.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An Indocyanine Green-Based Nanoprobe for In Vivo Detection of Cellular Senescence.

Autor: Baker AG; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK.; Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK., Hartono M; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK.; Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK., Ou HL; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK., Popov AB; Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK., Brown EL; Department of Physics, University of, Cambridge, JJ Thomson Avenue, CB3 0HE, United Kingdom.; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK., Joseph J; Department of Physics, University of, Cambridge, JJ Thomson Avenue, CB3 0HE, United Kingdom.; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK.; School of Science and Engineering, University of Dundee, Dundee, DD1 4HN, Scotland, UK., Golinska M; Department of Physics, University of, Cambridge, JJ Thomson Avenue, CB3 0HE, United Kingdom.; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK., González-Gualda E; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK., Macias D; Instituto de Biomedicina de Sevilla, IBIS/Hospital Universitario Virgen del Rocio, Universidad de Sevilla, Avda.Dr. Fedriani/>, Sevilla, 41009, Spain., Ge J; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK., Denholm M; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK., Morsli S; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK., Sanghera C; Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK., Else TR; Department of Physics, University of, Cambridge, JJ Thomson Avenue, CB3 0HE, United Kingdom.; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK., Greer HF; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK., Vernet A; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK., Bohndiek SE; Department of Physics, University of, Cambridge, JJ Thomson Avenue, CB3 0HE, United Kingdom.; Cancer Research UK Cambridge Institute, Robinson Way, Cambridge, CB2 0RE, UK., Muñoz-Espín D; Early Cancer institute, Department of Oncology, University of Cambridge, Hills Road, Cambridge, CB2 0XZ, UK.; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK., Fruk L; Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge, CB3 0AS, UK.; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.

Publikováno v: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2024 Jun 17; Vol. 63 (25), pp. e202404885. Date of Electronic Publication: 2024 May 16.